Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Gurnet Point Capital is a private equity firm that invests in healthcare and life sciences companies, including biopharma, diagnostics, and healthcare services. The firm utilizes a hybrid venture and private equity approach, providing both capital and strategic guidance to its portfolio companies from product development through commercialization. It manages an initial capital allocation of $2 billion, primarily funded by the Bertarelli family through Waypoint Capital, and has a global investment focus with portfolio companies in the United States and Israel.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Gurnet Point Capital's most recent investment?
- Gurnet Point Capital participated in a Series A round for Fairtility in May 2022, which raised $18.5M.
- In which sector does Gurnet Point Capital primarily invest?
- Gurnet Point Capital shows a focus on the Health Tech & Life Sciences sector, with its sole recorded investment in Fairtility falling within this category.
- What stage of funding does Gurnet Point Capital typically target?
- Gurnet Point Capital has invested in an A Round, specifically for Fairtility.
- Can you name a notable company in Gurnet Point Capital's portfolio?
- Fairtility, an AI-powered IVF solutions provider, is a notable company in Gurnet Point Capital's portfolio, having received Series A funding in May 2022.
- What is the typical investment range for Gurnet Point Capital?
- Gurnet Point Capital's investment range is stated as $15M - $15M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2013 |
|---|